PlexusDx accepts HSA and FSA funds, reducing your out-of-pocket cost by up to 35% depending on your account balance and tax bracket
While three other evaluations of the GT Plus assay have previously been published 11,33,34 , the present study investigated HCV-1 specimens including the largest collection of very challenging clinical specimens with ambiguous HCV-1 results by GT II from three different geographical regions that was ever tested with the GT Plus assay and subsequently evaluated by a reference method for confirmation
April 14, 2026 Cagrilintide long term weight maintenance research covering chronic body composition, metabolic stability, combined cagrisema dosing, and rodent obesity model outcomes
Drugmakers Novo Nordisk and Eli Lilly are facing a possible wave of lawsuits over claims they failed to warn patients that their diabetes and weight-loss drugs can cause severe health issues, including stomach paralysis and severe vomiting
10.1016/j.clpt.2005.09.002 86 HermansenK.KipnesM.LuoE.FanurikD.KhatamiH.SteinP.et al (2007)
500 The study revealed that patients receiving a single intravenous dose of ustekinumab (130 mg or 6 mg/kg) followed by a maintenance dose of 90 mg subcutaneously every 8 weeks experienced a significant reduction in symptoms such as rectal bleeding and no significant adverse events
